Discussion questions and Forum for 3/14/2019
Completion requirements
Hi all,
This week we will not have a live Journal club session. Instead, review the article and contribute to the discussion here by providing your thoughts on the following questions.
1) What findings or author's conclusions did you react to the most?
2) What are your key takeaways from this article?
3) Could any of the results or principles learned here be extrapolated to other demographics or other anti-psychotic drugs? Provide your rationale.
4) Any particular strengths or limitations of the study that warrant attention?
Happy reading!
SG